Positron, Disease Management to develop heart disease management tool

Positron Corporation and Disease Management have announced an agreement to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.??

The product will include a heart disease pre-test risk calculator; a Coronary Disease Reversal and Prevention practice management program; a web-based, patient-centric, disease-reversal and life-style modification program; an interpreting and referring physician portal as well as a cost-efficacy and patient-outcomes tracker, according to the Houston-based Positron.??

“The development of our heart disease management solution will help us reach beyond our current molecular imaging targeted business to offer a product to payors, self insured corporations, multi-specialty groups, cardiology groups, hospitals and finally direct to the consumer,” said Joseph G. Oliverio, president of Positron.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.